SCHEMBL6397173

SCHEMBL6397173

O=P(O)(O)c1cc(O)cc(O)c1CCc1cccc(O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.45
DRD1 P21728 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
GABRA1 P14867 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
CHRM2 P08172 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM3 P20309 2/20 0.41
F2 P00734 1/20 0.41
HTR2B P41595 1/20 0.41
OPRK1 P41145 1/20 0.41
POLB P06746 1/20 0.40
CALM1 P0DP23 1/20 0.40
TYR P14679 2/20 0.40
NR1H3 Q13133 1/20 0.40
ENPP2 Q13822 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6398018 0.91 MGLL (0.47) DRD2DRD1TAAR1GABRA1GABRG2
SCHEMBL6404256 0.91 SLC28A3 (0.47) DRD2DRD1TAAR1GABRA1GABRG2
SCHEMBL6395072 0.88 DRD2 (0.45) DRD2DRD1TAAR1GABRA1GABRG2
SCHEMBL6398088 0.84 SLC28A3 (0.53) TAAR1POLBTYR
SCHEMBL6397460 0.80 DRD2 (0.46) DRD2DRD1TAAR1GABRA1GABRG2
SCHEMBL6397457 0.79 MGLL (0.43) DRD2DRD1TAAR1CHRM2CHRM1
SCHEMBL6403912 0.79 MGLL (0.47) DRD2DRD1TAAR1CHRM2CHRM1
SCHEMBL6403662 0.79 SLC5A1 (0.57) DRD2DRD1TAAR1GABRA1GABRG2
SCHEMBL6397171 0.78 DRD2 (0.41) DRD2DRD1TAAR1GABRA1GABRG2
SCHEMBL6397718 0.78 F2 (0.45) DRD2DRD1TAAR1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-6787528-B2 THERAPY FOR KIDNEY DISEASES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-09-07 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation PEERCE BRIAN E (US) 2002-09-19 US disclosed
US-6355823-B1 MEMBRANE SUBSTRATE PHOSPHATED FOR DRUGS FOR GASTROINTESTINAL DISORDERS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 DRD2 1797/4885DRD1 1654/4885TAAR1 2528/4885
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation SLC10A2, SLC34A3, SLC34A1 DRD2 1795/4885DRD1 1781/4885TAAR1 2659/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 DRD2 1797/4885DRD1 1654/4885TAAR1 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.